Bacteria are the leading cause of infections after solid organ transplantation. In recent years,
a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug …

The advancements in surgical techniques, immunosuppressive therapies, and infection
control and prophylaxis, along with significant changes in the policy of graft recruitment and …

Enterobacteriaceae; ESBL, extended-spectrum beta-lactamase; EUCAST, European
Committee on Antimicrobial Susceptibility Testing; FDA, Food and Drug Administration; ICU …

C. van Deldena,∗, EA Blumbergb and The AST Infectious Diseases Community of Practice
aService of Transplantation, Department of Surgery, University Hospital Geneva …

Overall, donor and recipient colonization is associated with an increased risk of infection by
MDR GNB, although none of these circumstances constitutes an absolute contraindication to …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Bacterial infections are a leading cause of morbidity and mortality among solid organ
transplant recipients. Over the last two decades, various multidrug-resistant (MDR) …

Solid organ transplant (SOT) recipients are especially at risk of developing infections by
multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to …

Background Although infections due to the six ESKAPE pathogens have recently been
identified as a serious emerging problem, information regarding bacteremia caused by …

Hematopoietic stem cell transplant (HSCT) recipients are uniquely threatened by the
emergence of multidrug‐resistant (MDR) bacteria because these patients rely on immediate …